Preclinical Investigations of PM01183 (Lurbinectedin) as a Single Agent or in Combination with Other Anticancer Agents for Clear Cell Carcinoma of the OvaryRyoko Takahashi, Tadashi Kimura|PLoS ONE|2016Cited by 34